Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management.
Female
Humans
Male
Black or African American
/ statistics & numerical data
Colonic Neoplasms
/ epidemiology
Ethnicity
/ statistics & numerical data
Healthcare Disparities
/ ethnology
Hispanic or Latino
/ statistics & numerical data
United States
/ epidemiology
Race Factors
/ statistics & numerical data
Treatment Outcome
Health Services Accessibility
/ statistics & numerical data
East Asian People
/ statistics & numerical data
Southeast Asian People
/ statistics & numerical data
South Asian People
/ statistics & numerical data
Native Hawaiian or Other Pacific Islander
/ statistics & numerical data
Asian
/ statistics & numerical data
Databases, Factual
/ statistics & numerical data
American Indian or Alaska Native
/ statistics & numerical data
Racial Groups
/ statistics & numerical data
Colon cancer
Colorectal surgery
Healthcare access
Racial disparities
Journal
International journal for equity in health
ISSN: 1475-9276
Titre abrégé: Int J Equity Health
Pays: England
ID NLM: 101147692
Informations de publication
Date de publication:
14 04 2023
14 04 2023
Historique:
received:
18
09
2022
accepted:
04
04
2023
medline:
18
4
2023
entrez:
14
4
2023
pubmed:
15
4
2023
Statut:
epublish
Résumé
Colorectal cancer is a leading cause of morbidity and mortality across U.S. racial/ethnic groups. Existing studies often focus on a particular race/ethnicity or single domain within the care continuum. Granular exploration of disparities among different racial/ethnic groups across the entire colon cancer care continuum is needed. We aimed to characterize differences in colon cancer outcomes by race/ethnicity across each stage of the care continuum. We used the 2010-2017 National Cancer Database to examine differences in outcomes by race/ethnicity across six domains: clinical stage at presentation; timing of surgery; access to minimally invasive surgery; post-operative outcomes; utilization of chemotherapy; and cumulative incidence of death. Analysis was via multivariable logistic or median regression, with select demographics, hospital factors, and treatment details as covariates. 326,003 patients (49.6% female, 24.0% non-White, including 12.7% Black, 6.1% Hispanic/Spanish, 1.3% East Asian, 0.9% Southeast Asian, 0.4% South Asian, 0.3% AIAE, and 0.2% NHOPI) met inclusion criteria. Relative to non-Hispanic White patients: Southeast Asian (OR 1.39, p < 0.01), Hispanic/Spanish (OR 1.11 p < 0.01), and Black (OR 1.09, p < 0.01) patients had increased odds of presenting with advanced clinical stage. Southeast Asian (OR 1.37, p < 0.01), East Asian (OR 1.27, p = 0.05), Hispanic/Spanish (OR 1.05 p = 0.02), and Black (OR 1.05, p < 0.01) patients had increased odds of advanced pathologic stage. Black patients had increased odds of experiencing a surgical delay (OR 1.33, p < 0.01); receiving non-robotic surgery (OR 1.12, p < 0.01); having post-surgical complications (OR 1.29, p < 0.01); initiating chemotherapy more than 90 days post-surgery (OR 1.24, p < 0.01); and omitting chemotherapy altogether (OR 1.12, p = 0.05). Black patients had significantly higher cumulative incidence of death at every pathologic stage relative to non-Hispanic White patients when adjusting for non-modifiable patient factors (p < 0.05, all stages), but these differences were no longer statistically significant when also adjusting for modifiable factors such as insurance status and income. Non-White patients disproportionately experience advanced stage at presentation. Disparities for Black patients are seen across the entire colon cancer care continuum. Targeted interventions may be appropriate for some groups; however, major system-level transformation is needed to address disparities experienced by Black patients.
Sections du résumé
BACKGROUND
Colorectal cancer is a leading cause of morbidity and mortality across U.S. racial/ethnic groups. Existing studies often focus on a particular race/ethnicity or single domain within the care continuum. Granular exploration of disparities among different racial/ethnic groups across the entire colon cancer care continuum is needed. We aimed to characterize differences in colon cancer outcomes by race/ethnicity across each stage of the care continuum.
METHODS
We used the 2010-2017 National Cancer Database to examine differences in outcomes by race/ethnicity across six domains: clinical stage at presentation; timing of surgery; access to minimally invasive surgery; post-operative outcomes; utilization of chemotherapy; and cumulative incidence of death. Analysis was via multivariable logistic or median regression, with select demographics, hospital factors, and treatment details as covariates.
RESULTS
326,003 patients (49.6% female, 24.0% non-White, including 12.7% Black, 6.1% Hispanic/Spanish, 1.3% East Asian, 0.9% Southeast Asian, 0.4% South Asian, 0.3% AIAE, and 0.2% NHOPI) met inclusion criteria. Relative to non-Hispanic White patients: Southeast Asian (OR 1.39, p < 0.01), Hispanic/Spanish (OR 1.11 p < 0.01), and Black (OR 1.09, p < 0.01) patients had increased odds of presenting with advanced clinical stage. Southeast Asian (OR 1.37, p < 0.01), East Asian (OR 1.27, p = 0.05), Hispanic/Spanish (OR 1.05 p = 0.02), and Black (OR 1.05, p < 0.01) patients had increased odds of advanced pathologic stage. Black patients had increased odds of experiencing a surgical delay (OR 1.33, p < 0.01); receiving non-robotic surgery (OR 1.12, p < 0.01); having post-surgical complications (OR 1.29, p < 0.01); initiating chemotherapy more than 90 days post-surgery (OR 1.24, p < 0.01); and omitting chemotherapy altogether (OR 1.12, p = 0.05). Black patients had significantly higher cumulative incidence of death at every pathologic stage relative to non-Hispanic White patients when adjusting for non-modifiable patient factors (p < 0.05, all stages), but these differences were no longer statistically significant when also adjusting for modifiable factors such as insurance status and income.
CONCLUSIONS
Non-White patients disproportionately experience advanced stage at presentation. Disparities for Black patients are seen across the entire colon cancer care continuum. Targeted interventions may be appropriate for some groups; however, major system-level transformation is needed to address disparities experienced by Black patients.
Identifiants
pubmed: 37060065
doi: 10.1186/s12939-023-01883-w
pii: 10.1186/s12939-023-01883-w
pmc: PMC10105474
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
68Subventions
Organisme : NCI NIH HHS
ID : T32 CA251070
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Ann Surg Oncol. 2015 Sep;22(9):2902-11
pubmed: 25652051
Am J Cardiol. 2017 Apr 15;119(8):1127-1134
pubmed: 28237284
J Gastrointest Oncol. 2016 Apr;7(Suppl 1):S32-43
pubmed: 27034811
Gynecol Oncol. 2014 May;133(2):238-41
pubmed: 24613675
Breast Cancer Res Treat. 2013 Oct;141(3):461-70
pubmed: 24062208
J Gen Intern Med. 2015 Aug;30 Suppl 3:S568-75
pubmed: 26105670
Am J Prev Med. 2014 Mar;46(3):228-36
pubmed: 24512861
J Community Health. 2017 Oct;42(5):1044-1061
pubmed: 28439739
J Clin Gastroenterol. 2020 Sep;54(8):714-719
pubmed: 32520886
N Engl J Med. 2007 Sep 20;357(12):1221-8
pubmed: 17881753
Br J Cancer. 2009 Dec 3;101 Suppl 2:S92-S101
pubmed: 19956172
JAMA Intern Med. 2020 Mar 1;180(3):463-466
pubmed: 31841583
Int J Equity Health. 2015 Oct 29;14:109
pubmed: 26511360
J Cancer Educ. 2010 Jun;25(2):146-52
pubmed: 20094825
Am J Surg. 2021 Aug;222(2):402-407
pubmed: 33602480
Ann Epidemiol. 2017 Nov;27(11):731-738.e1
pubmed: 29173578
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Cancer. 2017 Dec 15;123 Suppl 24:5014-5036
pubmed: 29205304
World J Gastroenterol. 2014 Jan 28;20(4):869-76
pubmed: 24574761
Cancer. 2010 Oct 1;116(19):4622-31
pubmed: 20626015
Updates Surg. 2019 Sep;71(3):523-531
pubmed: 30788664
Am J Public Health. 2010 Oct;100(10):1912-6
pubmed: 20724684
J Urol. 2013 Feb;189(2):514-20
pubmed: 23253307
JAMA Netw Open. 2020 Jan 3;3(1):e1918911
pubmed: 31922557
Ethn Dis. 2013 Summer;23(3):343-8
pubmed: 23914421
Am J Gastroenterol. 2015 Oct;110(10):1388-94
pubmed: 25964227
J Natl Med Assoc. 2010 Apr;102(4):303-11
pubmed: 20437737
Curr Opin Cardiol. 2021 May 1;36(3):335-339
pubmed: 33769383
J Cancer Educ. 2018 Aug;33(4):757-768
pubmed: 28378200
J Clin Oncol. 2012 Feb 1;30(4):401-5
pubmed: 22184373
Br J Gen Pract. 2020 Jun 25;70(696):e463-e471
pubmed: 32540874
Am J Prev Med. 2016 Dec;51(6):e155-e163
pubmed: 27476382
Ethn Health. 2011 Dec;16(6):501-18
pubmed: 22050536
J Racial Ethn Health Disparities. 2018 Dec;5(6):1346-1353
pubmed: 29603075
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
J Natl Compr Canc Netw. 2021 Mar 02;19(3):329-359
pubmed: 33724754
J Community Med Health Educ. 2013 Jan 25;3:
pubmed: 24244894
JAMA. 2011 Sep 7;306(9):942-51
pubmed: 21900134
J Health Serv Res Policy. 2012 Apr;17(2):110-8
pubmed: 22008712
Medicine (Baltimore). 2008 Jan;87(1):1-9
pubmed: 18204365
Cancer. 2006 Jul 1;107(1):184-92
pubmed: 16721803
Laryngoscope. 2019 Mar;129(3):643-654
pubmed: 30152118
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4296-301
pubmed: 27044069
Asia Pac J Clin Oncol. 2020 Aug;16(4):193-200
pubmed: 32129941
Eur J Cancer Care (Engl). 2017 Jan;26(1):
pubmed: 27515153
Ethn Dis. 2013 Summer;23(3):349-55
pubmed: 23914422
Cancer Causes Control. 2014 Apr;25(4):419-23
pubmed: 24445597
J Womens Health (Larchmt). 2020 Sep;29(9):1192-1202
pubmed: 32096681
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e136-41
pubmed: 23219014
Gut. 2021 Dec;70(12):2321-2329
pubmed: 33495268
J Surg Oncol. 2014 Jun;109(7):629-30
pubmed: 24464362
Cancer Causes Control. 2016 Aug;27(8):989-98
pubmed: 27372292
J Med Ethics. 2006 Jun;32(6):346-50
pubmed: 16731734
J Psychosoc Oncol. 2008;26(2):63-86
pubmed: 18285301
Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):3-12
pubmed: 33144285
Surg Endosc. 2020 Jun;34(6):2651-2656
pubmed: 31372887
Ethn Dis. 2013 Winter;23(1):29-34
pubmed: 23495619
Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):384-391
pubmed: 30333221
Am J Public Health. 1997 Nov;87(11):1773-8
pubmed: 9366634
Eur J Surg Oncol. 2018 Oct;44(10):1479-1485
pubmed: 30251641
Cancer Causes Control. 2012 May;23(5):691-702
pubmed: 22460700
Dis Colon Rectum. 2017 Dec;60(12):1241-1249
pubmed: 29112559
J Gen Intern Med. 2003 Dec;18(12):1028-35
pubmed: 14687262
Ann Surg Oncol. 2014 Nov;21(12):3909-16
pubmed: 24849522
JAMA Surg. 2013 Aug;148(8):747-54
pubmed: 23784448
Cancer Med. 2015 Dec;4(12):1863-70
pubmed: 26471963
J Community Health. 2017 Aug;42(4):724-729
pubmed: 28040840
Teach Learn Med. 2022 Jun-Jul;34(3):238-245
pubmed: 33934678
JAMA Netw Open. 2020 Jan 03;3(1):e1920010
pubmed: 31995215
JAMA Netw Open. 2020 Sep 1;3(9):e2016019
pubmed: 32902648